322 related articles for article (PubMed ID: 12771636)
1. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
McGee WT; Tereso GJ
Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
[TBL] [Abstract][Full Text] [Related]
2. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin.
Olver WJ; Scott F; Shankland GS
Med Mycol; 2006 Nov; 44(7):655-7. PubMed ID: 17071561
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
[TBL] [Abstract][Full Text] [Related]
5. Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin.
Fanci R; Guidi S; Bonolis M; Bosi A
Bone Marrow Transplant; 2005 Jun; 35(12):1215-6. PubMed ID: 15852027
[No Abstract] [Full Text] [Related]
6. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.
Golan Y; Wolf MP; Pauker SG; Wong JB; Hadley S
Ann Intern Med; 2005 Dec; 143(12):857-69. PubMed ID: 16365467
[TBL] [Abstract][Full Text] [Related]
7. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
[No Abstract] [Full Text] [Related]
9. Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Pan SC; Hsieh SM; Chang SC; Lee HT; Chen YC
Med Mycol; 2005 Dec; 43(8):731-4. PubMed ID: 16422304
[TBL] [Abstract][Full Text] [Related]
10. Antifungal pharmacotherapy for neonatal candidiasis.
Bliss JM; Wellington M; Gigliotti F
Semin Perinatol; 2003 Oct; 27(5):365-74. PubMed ID: 14626500
[TBL] [Abstract][Full Text] [Related]
11. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.
Colombo AL; Perfect J; DiNubile M; Bartizal K; Motyl M; Hicks P; Lupinacci R; Sable C; Kartsonis N
Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):470-4. PubMed ID: 12884068
[TBL] [Abstract][Full Text] [Related]
12. Echinocandins--an advance in the primary treatment of invasive candidiasis.
Walsh TJ
N Engl J Med; 2002 Dec; 347(25):2070-2. PubMed ID: 12490691
[No Abstract] [Full Text] [Related]
13. Caspofungin versus amphotericin B for invasive candidiasis.
Brown AL; Greig JR
N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
[No Abstract] [Full Text] [Related]
14. Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin.
Sim JP; Kho BC; Liu HS; Yung R; Chan JC
Hong Kong Med J; 2005 Apr; 11(2):120-3. PubMed ID: 15815067
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis.
Elanjikal Z; Sörensen J; Schmidt H; Dupuis W; Tintelnot K; Jautzke G; Klingebiel T; Lehrnbecher T
Pediatr Infect Dis J; 2003 Jul; 22(7):653-6. PubMed ID: 12867844
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin in a pediatric patient with persistent candidemia.
Wertz KK; Pretzlaff RK
Pediatr Crit Care Med; 2004 Mar; 5(2):181-3. PubMed ID: 14987350
[TBL] [Abstract][Full Text] [Related]
17. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
19. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Gahn B; Schub N; Repp R; Gramatzki M
Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K
Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]